{"result": {"id": "chatcmpl-BBxvG98HoJq5Cm9HyaVkzkJnwtOHw", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>M. RUMMAN<|>PERSON<|>M. Rumman is a researcher who authored a concise review on quiescence in adult stem cells and its relevance to tissue regeneration.)\n##\n(\"entity\"<|>J. DHAWAN<|>PERSON<|>J. Dhawan is a researcher who contributed to the review on quiescence in adult stem cells and its biological significance.)\n##\n(\"entity\"<|>M. KASSEM<|>PERSON<|>M. Kassem is a researcher involved in the study of quiescence in adult stem cells and their role in tissue regeneration.)\n##\n(\"entity\"<|>T.H. CHEUNG<|>PERSON<|>T.H. Cheung is a researcher who discussed the molecular regulation of stem cell quiescence in a review article.)\n##\n(\"entity\"<|>T.A. RANDO<|>PERSON<|>T.A. Rando is a researcher who has contributed to the understanding of molecular regulation of stem cell quiescence.)\n##\n(\"entity\"<|>L. ROSSI<|>PERSON<|>L. Rossi is a researcher who has worked on uncovering the functional core of hematopoietic stem cells through knockout mice studies.)\n##\n(\"entity\"<|>H.A. COLLER<|>PERSON<|>H.A. Coller is a researcher who provided a new description of cellular quiescence in a published article.)\n##\n(\"entity\"<|>M.S. SOSA<|>PERSON<|>M.S. Sosa is a researcher who explored mechanisms of disseminated cancer cell dormancy in a review article.)\n##\n(\"entity\"<|>P. BRAGADO<|>PERSON<|>P. Bragado is a researcher who has contributed to the understanding of mechanisms related to cancer cell dormancy.)\n##\n(\"entity\"<|>J.A. AGUIRRE-GHISO<|>PERSON<|>J.A. Aguirre-Ghiso is a researcher who has studied mechanisms of disseminated cancer cell dormancy.)\n##\n(\"entity\"<|>J. OH<|>PERSON<|>J. Oh is a researcher who has discussed stem cell aging and its therapeutic opportunities in a review article.)\n##\n(\"entity\"<|>Y.D. LEE<|>PERSON<|>Y.D. Lee is a researcher who has contributed to the study of stem cell aging and its mechanisms.)\n##\n(\"entity\"<|>A.J. WAGERS<|>PERSON<|>A.J. Wagers is a researcher who has explored stem cell aging and its implications for therapy.)\n##\n(\"entity\"<|>N.E. SHARPLESS<|>PERSON<|>N.E. Sharpless is a researcher who has discussed how stem cells age and its implications for aging in general.)\n##\n(\"entity\"<|>R.A. DEPINHO<|>PERSON<|>R.A. DePinho is a researcher who has contributed to the understanding of stem cell aging and its effects on growth.)\n##\n(\"entity\"<|>J.T. RODGERS<|>PERSON<|>J.T. Rodgers is a researcher who studied the role of mTORC1 in the adaptive transition of quiescent stem cells.)\n##\n(\"entity\"<|>N.L. BUCHER<|>PERSON<|>N.L. Bucher is a researcher who has worked on the regeneration of mammalian liver.)\n##\n(\"entity\"<|>G.S. ROTH<|>PERSON<|>G.S. Roth is a researcher who studied age-dependent regulation of DNA synthesis and cell division in mammals.)\n##\n(\"entity\"<|>T.A. OWEN<|>PERSON<|>T.A. Owen is a researcher who analyzed growth factor requirements for stimulation of WI-38 cells after growth arrest.)\n##\n(\"entity\"<|>D.R. SOPRANO<|>PERSON<|>D.R. Soprano is a researcher who has worked on the growth factor requirements for WI-38 cells.)\n##\n(\"entity\"<|>K.J. SOPRANO<|>PERSON<|>K.J. Soprano is a researcher involved in the analysis of growth factor requirements for WI-38 cells.)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": [], "audio": null, "function_call": null, "tool_calls": null}}], "created": 1742191650, "model": "gpt-4o-mini-2024-07-18", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_3267753c5d", "usage": {"completion_tokens": 886, "prompt_tokens": 5288, "total_tokens": 6174, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 4224}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n\n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [research article, person, cell type, biological process, gene, institution, factor]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n\n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: an integer score between 1 to 10, indicating strength of the relationship between the source entity and target entity\nFormat each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n\n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n\n4. If you have to translate into English, just translate the descriptions, nothing else!\n\n5. When finished, output <|COMPLETE|>.\n\n-Examples-\n######################\n\nExample 1:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\n Become Activated upon Brain Injury.Cell Stem Cell2015,17, 329–340. [CrossRef]\n44.Rodgers, J.T.; Schroeder, M.D.; Ma, C.; Rando, T.A. HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of\nStem Cells into GAlert.Cell Rep.2017,19, 479–486. [CrossRef]\n45.Lee, G.; Espirito Santo, A.I.; Zwingenberger, S.; Cai, L.; Vogl, T.; Feldmann, M.; Horwood, N.J.; Chan, J.K.; Nanchahal, J. Fully\nreduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert.Proc. Natl. Acad. Sci. USA\n2018,115, E4463–E4472.\n46. Baker, D.J.; Sedivy, J.M. Probing the depths of cellular senescence. J. Cell Biol.2013,202, 11–13. [CrossRef]\n47. Van Deursen, J.M. The role of senescent cells in ageing. Nature2014,509,\n------------------------\noutput:\n(\"entity\"<|>CELL STEM CELL<|>RESEARCH ARTICLE<|>A research article published in Cell Stem Cell in 2015 discussing activation upon brain injury)\n##\n(\"entity\"<|>HGFA<|>FACTOR<|>HGFA is an injury-regulated systemic factor that induces the transition of stem cells into GAlert)\n##\n(\"entity\"<|>GAlert<|>CELL TYPE<|>GAlert is a state of stem cells that is induced by HGFA during injury)\n##\n(\"entity\"<|>CELL REPORT<|>RESEARCH ARTICLE<|>A research article published in Cell Reports in 2017 discussing the role of HGFA in stem cell transition)\n##\n(\"entity\"<|>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA<|>RESEARCH ARTICLE<|>A research article published in PNAS in 2018 discussing the effects of fully reduced HMGB1 on tissue regeneration)\n##\n(\"entity\"<|>HMGB1<|>FACTOR<|>HMGB1 is a factor that accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert)\n##\n(\"entity\"<|>JOURNAL OF CELL BIOLOGY<|>RESEARCH ARTICLE<|>A research article published in the Journal of Cell Biology in 2013 discussing cellular senescence)\n##\n(\"entity\"<|>NATURE<|>RESEARCH ARTICLE<|>A research article published in Nature in 2014 discussing the role of senescent cells in aging)\n##\n(\"entity\"<|>D.J. BAKER<|>PERSON<|>D.J. Baker is a researcher who has probed the depths of cellular senescence)\n##\n(\"entity\"<|>J.M. SEDIVY<|>PERSON<|>J.M. Sedivy is a researcher who has probed the depths of cellular senescence)\n##\n(\"entity\"<|>J.M. VAN DEURSEN<|>PERSON<|>J.M. Van Deursen is a researcher discussing the role of senescent cells in aging)\n##\n(\"relationship\"<|>HGFA<|>GAlert<|>HGFA induces the transition of stem cells into GAlert<|>8)\n##\n(\"relationship\"<|>HMGB1<|>GAlert<|>Fully reduced HMGB1 accelerates the regeneration of tissues by transitioning stem cells to GAlert<|>8)\n##\n(\"relationship\"<|>D.J. BAKER<|>JOURNAL OF CELL BIOLOGY<|>D.J. Baker authored a research article discussing cellular senescence in the Journal of Cell Biology<|>7)\n##\n(\"relationship\"<|>J.M. SEDIVY<|>JOURNAL OF CELL BIOLOGY<|>J.M. Sedivy authored a research article discussing cellular senescence in the Journal of Cell Biology<|>7)\n##\n(\"relationship\"<|>J.M. VAN DEURSEN<|>NATURE<|>J.M. Van Deursen authored a research article discussing the role of senescent cells in aging in Nature<|>7)\n<|COMPLETE|>\n#############################\n\n\nExample 2:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\nshort exposure (6 h) to either drug was sufficient to inhibit ly-\n\nsosomal function in REF cells, evident by the impaired pro-\n\nteolytic degradation within the lysosomal compartment (\n\nSI\n\nAppendix\n\n, Fig. S5\nA\n). When quiescent cells were treated with\n\neither of these 2 lysosomal inhibitors, increasingly higher serum\nconcentrations were required to activate cells to reenter the cell\n\ncycle, in a drug dose-dependent manner (Fig. 4\n\nB\n–\nD\n; red arrow\n\npoints to serum concentration for activating\n\n∼\n50% of cells, judged\n\nbased on EdU incorporation, E2f-GFP reporter, and propidium\n\niodide [PI] staining, respectively). Correspondingly, at a given\nserum concentration (e.g., 4% serum), a decreasing percentage of\n\ncells were able to reenter the cell cycle (EdU\n+\n)withanincreasing\n\ndose of either lysosomal inhibitor, Baf or CQ (Fig. 4\n\nB\n). The ly-\n\nsosomal inhibition-caused quiescence deepening occurred re-\n\ngardless of the preceding quiescence depth before drug treatment:\n\nAs shown in\n\n\n------------------------\noutput:\n(\"entity\"<|>REF CELLS<|>CELL TYPE<|>REF cells are a type of cell used in research that exhibit lysosomal function and are affected by drug treatments.)\n##\n(\"entity\"<|>LYSOSOMAL INHIBITORS<|>FACTOR<|>Lysosomal inhibitors are substances that impair lysosomal function, affecting cellular processes such as proteolytic degradation.)\n##\n(\"entity\"<|>BAF<|>FACTOR<|>Baf is a specific lysosomal inhibitor that affects the reentry of quiescent cells into the cell cycle.)\n##\n(\"entity\"<|>CQ<|>FACTOR<|>CQ is another lysosomal inhibitor that impacts the ability of quiescent cells to reactivate and reenter the cell cycle.)\n##\n(\"entity\"<|>EDU INCORPORATION<|>BIOLOGICAL PROCESS<|>EdU incorporation is a method used to measure cell proliferation by detecting newly synthesized DNA in cells.)\n##\n(\"entity\"<|>E2F-GFP REPORTER<|>BIOLOGICAL PROCESS<|>E2F-GFP reporter is a tool used to monitor cell cycle progression and activation in response to serum concentrations.)\n##\n(\"entity\"<|>PROPIDIUM IODIDE STAINING<|>BIOLOGICAL PROCESS<|>Propidium iodide staining is a technique used to assess cell viability and cell cycle status by staining DNA.)\n##\n(\"relationship\"<|>REF CELLS<|>LYSOSOMAL INHIBITORS<|>Lysosomal inhibitors impair the lysosomal function in REF cells, affecting their ability to degrade proteins and reenter the cell cycle.<|>8)\n##\n(\"relationship\"<|>REF CELLS<|>BAF<|>Baf treatment leads to a dose-dependent inhibition of REF cells' ability to reenter the cell cycle.<|>7)\n##\n(\"relationship\"<|>REF CELLS<|>CQ<|>CQ treatment also inhibits REF cells' ability to reactivate and reenter the cell cycle in a dose-dependent manner.<|>7)\n##\n(\"relationship\"<|>REF CELLS<|>EDU INCORPORATION<|>EdU incorporation is used to assess the percentage of REF cells that can reenter the cell cycle after treatment with lysosomal inhibitors.<|>6)\n##\n(\"relationship\"<|>REF CELLS<|>E2F-GFP REPORTER<|>The E2F-GFP reporter is utilized to monitor the activation of REF cells in response to serum concentrations.<|>6)\n##\n(\"relationship\"<|>REF CELLS<|>PROPIDIUM IODIDE STAINING<|>Propidium iodide staining is employed to evaluate the cell cycle status of REF cells after treatment with lysosomal inhibitors.<|>6)\n<|COMPLETE|>\n#############################\n\n\nExample 3:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\n lysosomal function continuously modulates quiescence\ndepth, acting like a dimmer switch (Fig. 6\n\nH\n).\n\nQuiescence Deepening Is Linked to Cellular Senescence and Aging.\n\nFinally, we examined whether and how deep quiescence in REF\n\ncells is related to the quiescent states of other cell types (case Q)\nand other nongrowth cellular states, such as senescence (case S).\n\nTo this end, we first developed a gene-expression signature in-\n\ndicating the quiescence depth in REF cells by performing a\nlinear regression analysis of the time-course RNA-seq data (see\n\nMaterials and Methods\n\nfor details). To identify a signature that\n\ncorresponds to a deepening of quiescence as opposed to simply\n\nhalting the cell cycle, we omitted the proliferating sample (0 d) from\nthe analysis and used samples corresponding to 2- to 16-d\nserum\n\nstarvation (i.e., shallow to deep quiescence) to build the regression\n\nmodel. We next applied this quiescence-depth signature to other\npublicly available RNA-seq datase\nts related to cases Q and S, above.\n\nAB CD\n\nE\n\nGH\n\nF\n\n\n\n------------------------\noutput:\n(\"entity\"<|>LYSOSOMAL FUNCTION<|>BIOLOGICAL PROCESS<|>Lysosomal function is involved in modulating cellular quiescence and is linked to cellular senescence and aging.)\n##\n(\"entity\"<|>QUIESCENCE<|>BIOLOGICAL PROCESS<|>Quiescence refers to a state of cellular dormancy where cells are not actively dividing but can be activated under certain conditions.)\n##\n(\"entity\"<|>CELLULAR SENESCENCE<|>BIOLOGICAL PROCESS<|>Cellular senescence is a state where cells cease to divide and can contribute to aging and tissue dysfunction.)\n##\n(\"entity\"<|>AGING<|>BIOLOGICAL PROCESS<|>Aging is the process of becoming older, characterized by a gradual decline in physiological function and increased susceptibility to diseases.)\n##\n(\"entity\"<|>REF CELLS<|>CELL TYPE<|>REF cells are a type of cell used in research to study quiescence and cellular responses to various stimuli.)\n##\n(\"entity\"<|>GENE-EXPRESSION SIGNATURE<|>GENE<|>A gene-expression signature is a specific pattern of gene expression that can indicate particular cellular states, such as quiescence depth.)\n##\n(\"relationship\"<|>LYSOSOMAL FUNCTION<|>QUIESCENCE<|>Lysosomal function modulates quiescence, affecting how cells enter and maintain this dormant state<|>8)\n##\n(\"relationship\"<|>QUIESCENCE<|>CELLULAR SENESCENCE<|>Quiescence is linked to cellular senescence, as both processes involve changes in cell cycle activity and can influence aging<|>7)\n##\n(\"relationship\"<|>CELLULAR SENESCENCE<|>AGING<|>Cellular senescence contributes to the aging process by promoting tissue dysfunction and limiting regenerative capacity<|>9)\n##\n(\"relationship\"<|>REF CELLS<|>QUIESCENCE<|>REF cells are used to study the mechanisms of quiescence and how it can be influenced by various factors<|>6)\n##\n(\"relationship\"<|>GENE-EXPRESSION SIGNATURE<|>QUIESCENCE<|>The gene-expression signature developed indicates the depth of quiescence in REF cells, providing insights into their cellular state<|>8)\n<|COMPLETE|>\n#############################\n\n\n\n-Real Data-\n######################\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext: single-\n\ncell clone derived from REF52 cells and contain a stably integrated human\n\nE2F1 promoter-driven destabilized EGFP (E2f-GFP) reporter, as previously\n\ndescribed [i.e., REF/E23 cells (25, 82)] unless otherwise noted. Cells were\n\npassaged every 2 to 3 d and maintained at subconfluency in growth me-\n\ndium: DMEM supplemented with 10% bovine growth serum (BGS; GE\n\nHealthcare, SH30541). To induce quiescence, cells were plated at\n\n∼\n50%\n\nconfluence in growth medium for a day, washed twice with DMEM, and\n\ncultured in serum-starvation medium (DMEM containing 0.02% BGS) for the\n\nindicated duration (\n\n≥\n2d).\n\n\nQuiescence-Depth Assay.\n\nTo assess quiescence depth, cells were switched from\n\nserum-starvation medium to serum-stimulation medium (DMEM containing\n\nBGS at indicated concentrations) and harvested at indicated time points by\n\ntrypsinization. The cell fraction that reentered the cell cycle was quantified by\n\nassessing the profile of EdU incorporation (and the profiles of E2f-GFP re-\n\nporter and PI DNA staining when indicated). Quiescence depth is determined\n\nby the serum threshold required to activate cells to reenter the cell cycle. At a\n\ngiven serum concentration, a smaller percentage of deeper quiescent cells are\n\nable to reenter the cell cycle by a given time than of shallower quiescent cells.\n\nSee text for details.\n\n\nData Availability.\n\nThe data reported in this paper have been deposited in the\n\nGene Expression Omnibus (GEO) database,\nhttps://www.ncbi.nlm.nih.gov/\n\ngeo\n(accession no. GSE124109).\n\n\nACKNOWLEDGMENTS.\n\nWe thank Johnny Fares for valuable discussions and\n\nsuggestions on lysosomal function and assays; Andrew Peak and Andrew\nCapaldi for critical reading and comments on the manuscript; and Haoxing\nXu for providing Mcoln1 inhibitors. This work was supported by National\nScience Foundation Grants DMS-1463137 (to G.Y.), DMS-1418172 (to G.Y.\nand H.H.Z.), CCF-1740858 (to H.H.Z.), and DMS-1462049 (to J.X.); National\nInstitutes of Health Grant R01DK119232 (to J.X.); Chinese National Science\nand Technology Major Project 2018ZX10302205 (to F.B.); and Guangdong\nProvince Key Research and Development Program 2019B020226002 (to F.B.).\n1. M. Rumman, J. Dhawan, M. Kassem, Concise review: Quiescence in adult stem cells:\n\nBiological significance and relevance to tissue regeneration.\n\nStem Cells\n33\n, 2903\n–\n2912\n\n(2015).\n\n2. T. H. Cheung, T. A. Rando, Molecular regulation of stem cell quiescence.\n\nNat. Rev.\n\nMol. Cell Biol.\n\n14\n, 329\n–\n340 (2013).\n\n3. L. Rossi\n\net al\n., Less is more: Unveiling the functional core of hematopoietic stem cells\n\nthrough knockout mice.\n\nCell Stem Cell\n11\n, 302\n–\n317 (2012).\n\n4. H. A. Coller, L. Sang, J. M. Roberts, A new description of cellular quiescence.\n\nPLoS Biol.\n\n\n4\n\n, e83 (2006).\n\n5. M. S. Sosa, P. Bragado, J. A. Aguirre-Ghiso, Mechanisms of disseminated cancer cell\n\ndormancy: An awakening field.\n\nNat. Rev. Cancer\n14\n, 611\n–\n622 (2014).\n\n6. J. Oh, Y. D. Lee, A. J. Wagers, Stem cell aging: Mechanisms, regulators and therapeutic\n\nopportunities.\n\nNat. Med.\n20\n, 870\n–\n880 (2014).\n\n7. N. E. Sharpless, R. A. DePinho, How stem cells age and why this makes us grow old.\n\n\nNat. Rev. Mol. Cell Biol.\n\n8\n, 703\n–\n713 (2007).\n\n8. J. T. Rodgers\n\net al\n., mTORC1 controls the adaptive transition of quiescent stem cells\n\nfrom G0 to G(Alert).\n\nNature\n510\n, 393\n–\n396 (2014).\n\n9. E. Llorens-Bobadilla\n\net al\n., Single-cell transcriptomics reveals a population of dormant\n\nneural stem cells that become activated upon brain injury.\n\nCell Stem Cell\n17\n, 329\n–\n340\n\n(2015).\n\n10. N. L. Bucher, Regeneration of mammalian liver.\n\nInt. Rev. Cytol.\n15\n, 245\n–\n300 (1963).\n\n11. G. S. Roth, R. C. Adelman, Age-dependent regulation of mammalian DNA synthesis\n\nand cell division in vivo by glucocorticoids.\n\nExp. Gerontol.\n9\n,27\n –\n31 (1974).\n\n12. T. A. Owen, D. R. Soprano, K. J. Soprano, Analysis of the growth factor requirements\n\nfor stimulation of WI-38 cells after extended periods of density-dependent growth\narrest.\n\nJ. Cell. Physiol.\n139\n, 424\n–\n431 (1989).\n\n13. L. H. Augenlicht, R. Baserga, Changes in the\n######################\noutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>REF52 CELLS<|>CELL TYPE<|>REF52 cells are a type of cell line used in research, derived from rat fibroblasts, and are utilized for studying cellular processes such as quiescence and cell cycle regulation.)\n##\n(\"entity\"<|>E2F1 PROMOTER-DRIVEN DESTABILIZED EGFP<|>FACTOR<|>E2F1 promoter-driven destabilized EGFP is a reporter system used to monitor cell cycle activity and quiescence in REF52 cells.)\n##\n(\"entity\"<|>QUIESCENCE<|>BIOLOGICAL PROCESS<|>Quiescence is a state of cellular dormancy where cells are not actively dividing but can be activated under certain conditions, such as serum stimulation.)\n##\n(\"entity\"<|>SERUM-STARVATION MEDIUM<|>FACTOR<|>Serum-starvation medium is a growth medium that lacks serum, used to induce quiescence in cells by depriving them of growth factors.)\n##\n(\"entity\"<|>SERUM-STIMULATION MEDIUM<|>FACTOR<|>Serum-stimulation medium is a growth medium that contains serum, used to reactivate quiescent cells and assess their ability to reenter the cell cycle.)\n##\n(\"entity\"<|>EDU INCORPORATION<|>BIOLOGICAL PROCESS<|>EdU incorporation is a method used to measure cell proliferation by detecting newly synthesized DNA in cells, indicating their reentry into the cell cycle.)\n##\n(\"entity\"<|>E2F-GFP REPORTER<|>BIOLOGICAL PROCESS<|>E2F-GFP reporter is a tool used to monitor cell cycle progression and activation in response to serum concentrations.)\n##\n(\"entity\"<|>PI DNA STAINING<|>BIOLOGICAL PROCESS<|>Propidium iodide (PI) DNA staining is a technique used to assess cell viability and cell cycle status by staining DNA.)\n##\n(\"entity\"<|>GENE EXPRESSION OMNIBUS<|>INSTITUTION<|>The Gene Expression Omnibus (GEO) is a public database for gene expression data, where datasets can be deposited and accessed for research purposes.)\n##\n(\"entity\"<|>NATIONAL SCIENCE FOUNDATION<|>INSTITUTION<|>The National Science Foundation (NSF) is a U.S. government agency that supports fundamental research and education in all the non-medical fields of science and engineering.)\n##\n(\"entity\"<|>NATIONAL INSTITUTES OF HEALTH<|>INSTITUTION<|>The National Institutes of Health (NIH) is a part of the U.S. Department of Health and Human Services and is the primary agency for conducting and supporting medical research.)\n##\n(\"relationship\"<|>REF52 CELLS<|>E2F1 PROMOTER-DRIVEN DESTABILIZED EGFP<|>The E2F1 promoter-driven destabilized EGFP is used in REF52 cells to monitor their cell cycle activity and quiescence<|>8)\n##\n(\"relationship\"<|>REF52 CELLS<|>QUIESCENCE<|>REF52 cells are used to study the mechanisms of quiescence and how they can be influenced by serum starvation and stimulation<|>7)\n##\n(\"relationship\"<|>QUIESCENCE<|>SERUM-STARVATION MEDIUM<|>Serum-starvation medium is employed to induce quiescence in REF52 cells by depriving them of growth factors<|>8)\n##\n(\"relationship\"<|>QUIESCENCE<|>SERUM-STIMULATION MEDIUM<|>Serum-stimulation medium is used to reactivate quiescent REF52 cells and assess their ability to reenter the cell cycle<|>8)\n##\n(\"relationship\"<|>REF52 CELLS<|>EDU INCORPORATION<|>EdU incorporation is used to quantify the fraction of REF52 cells that reenter the cell cycle after serum stimulation<|>6)\n##\n(\"relationship\"<|>REF52 CELLS<|>E2F-GFP REPORTER<|>The E2F-GFP reporter is utilized in REF52 cells to monitor their activation and progression through the cell cycle<|>6)\n##\n(\"relationship\"<|>REF52 CELLS<|>PI DNA STAINING<|>PI DNA staining is employed to evaluate the cell cycle status of REF52 cells after treatment with serum stimulation<|>6)\n##\n(\"relationship\"<|>GENE EXPRESSION OMNIBUS<|>REF52 CELLS<|>Data related to REF52 cells and their quiescence studies have been deposited in the Gene Expression Omnibus for public access<|>5)\n##\n(\"relationship\"<|>NATIONAL SCIENCE FOUNDATION<|>REF52 CELLS<|>Research involving REF52 cells has been supported by grants from the National Science Foundation<|>5)\n##\n(\"relationship\"<|>NATIONAL INSTITUTES OF HEALTH<|>REF52 CELLS<|>Studies on REF52 cells have received funding from the National Institutes of Health<|>5)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "gpt-4o-mini", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}